MIT News

Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.

By MIT News

1 min read
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Science & R&D

Related Insights